LALPATHLAB.NS Tiesioginiai signalai | Didinkite pelną su Getagraph.com

Live Chart Being Loaded With Signals

Commentary (29 bal. 2024 @ 10:56):

Stats
Šios dienos apimtis	329 588
Vidutinė apimtis	271 066
Rinkos kapitalizacija	195.49B
EPS	INR0 ( 2024-02-01 )
Kita pelno data	( INR6.03 ) 2024-05-08
Last Dividend	INR12.00 ( 2023-08-11 )
Next Dividend	INR0 ( N/A )
P/E	59.49
ATR14	INR3.05 (0.13%)

Tūris Koreliacija

Ilgas: -0.13 (neutral)

Trumpas: -0.53 (weak negative)

Signal:(12.961) Neutral

Dr. Lal PathLabs Limited Koreliacija

10 Labiausiai teigiamai susiję koreliacijos

10 Labiausiai neigiamai susiję koreliacijos

Ar žinojote?

Koreliacija yra statistinis rodiklis, aprašantis ryšį tarp dviejų kintamųjų. Jis svyruoja nuo -1 iki 1, kur -1 reiškia tobulo neigiamo ryšio koreliaciją (padidėjus vienam kintamajam, sumažėja kitas), 1 reiškia tobulo teigiamo ryšio koreliaciją (padidėjus vienam kintamajam, padidėja ir kitas), o 0 reiškia jokios koreliacijos (tarp kintamųjų nėra jokio ryšio).

Koreliacija gali būti naudojama analizuojant bet kurių dviejų kintamųjų ryšį, ne tik akcijų. Jis dažnai naudojamas finansų, ekonomikos, psichologijos ir kitose srityse.

Dr. Lal PathLabs Limited Koreliacija - Valiuta/Žaliavos

0.72
( moderate )

0.57
( weak )

-0.37
( neutral )

0.68
( moderate )

-0.51
( weak negative )

-0.54
( weak negative )

Dr. Lal PathLabs Limited Finansinės ataskaitos

Annual	2022
Pajamos:	INR20.17B
Bruto pelnas:	INR15.70B (77.83 %)
EPS:	INR28.82

FY	2022
Pajamos:	INR20.17B
Bruto pelnas:	INR15.70B (77.83 %)
EPS:	INR28.82

FY	2022
Pajamos:	INR20.87B
Bruto pelnas:	INR13.00B (62.31 %)
EPS:	INR41.70

FY	2021
Pajamos:	INR15.81B
Bruto pelnas:	INR11.84B (74.88 %)
EPS:	INR35.33

Financial Reports:

No articles found.

Dr. Lal PathLabs Limited Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
INR6.00 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR12.00 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)

Dr. Lal PathLabs Limited Dividend Information - Dividend Junior

Dividend Sustainability Score: 2.87 - low (50.00%) | Divividend Growth Potential Score: 3.08 - Decrease likely (38.37%)

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information

First Dividend	INR2.45	2016-07-20
Last Dividend	INR12.00	2023-08-11
Next Dividend	INR0	N/A
Payout Date	0000-00-00
Next Payout Date	N/A
# dividends	16	--
Total Paid Out	INR77.95	--
Avg. Dividend % Per Year	0.37%	--
Score	2.2	--
Div. Sustainability Score	2.87
Div.Growth Potential Score	3.08
Div. Directional Score	2.98	--

Next Divdend (Est)
(2024-06-10)

INR13.50 Estimate 3.71 %

Dividend Stability

0.30 Very Poor

Dividend Score

2.20

Pay Frequency

Semi-Annually

Yearly Payout

Year	Amount	Yield
2016	INR0	0.00%
2017	INR0	0.00%
2018	INR5.50	0.66%
2019	INR9.50	1.03%
2020	INR12.00	0.78%
2021	INR20.00	0.83%
2022	INR12.00	0.31%
2023	INR12.00	0.55%
2024	INR0	0.00%

Dividend Commentary

The company's low Dividend Sustainability Score (DSS) highlights potential challenges in upholding its current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In conclusion, a more vigilant stance is recommended given the company's tentative dividend landscape.

Top 10 dividend Companies for NSE

Symbol	Title	Last dividend	Frequency	Years Dividend	Yearly Dividend
SMSPHARMA.NS	Ex Dividend Junior	2023-09-22	Annually	18	0.12%
MINDTECK.NS	Dividend Junior	2023-08-04	Sporadic	8	0.28%
HBSL.NS	Dividend Junior	2023-08-11	Sporadic	12	0.78%
BEPL.NS	Dividend King	2023-07-25	Semi-Annually	20	4.91%
RADICO.NS	Dividend Junior	2023-09-14	Annually	22	0.24%
KHAICHEM.NS	No Dividend Player	2023-07-21	Annually	5	0.32%
EMAMIPAP.NS	Dividend Junior	2023-09-05	Annually	3	0.56%
AJANTPHARM.NS	Dividend Junior	2023-08-04	Annually	23	0.57%
SUNTV.NS	Dividend Knight	2023-08-22	Quarterly	19	1.94%
NAVNETEDUL.NS	Dividend Junior	2023-08-07	Annually	22	1.10%

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	0.152	1.500	6.96	10.00	[0 - 0.5]
returnOnAssetsTTM	0	1.200	0	0	[0 - 0.3]
returnOnEquityTTM	0.190	1.500	9.00	10.00	[0.1 - 1]
payoutRatioTTM	0	-1.000	0	0	[0 - 1]
currentRatioTTM	0	0.800	-5.00	-4.00	[1 - 3]
quickRatioTTM	0	0.800	-4.71	-3.76	[0.8 - 2.5]
cashRatioTTM	0	1.500	-1.111	-1.667	[0.2 - 2]
debtRatioTTM	0	-1.500	0	0	[0 - 0.6]
interestCoverageTTM	15.29	1.000	5.45	5.45	[3 - 30]
operatingCashFlowPerShareTTM	28.46	2.00	0.514	1.028	[0 - 30]
freeCashFlowPerShareTTM	28.46	2.00	10.00	10.00	[0 - 20]
debtEquityRatioTTM	0	-1.500	0	0	[0 - 2.5]
grossProfitMarginTTM	0.684	1.000	1.929	1.929	[0.2 - 0.8]
operatingProfitMarginTTM	0.224	1.000	7.52	7.52	[0.1 - 0.6]
cashFlowToDebtRatioTTM	0	1.000	-1.111	-1.111	[0.2 - 2]
assetTurnoverTTM	0	0.800	-3.33	-2.67	[0.5 - 2]
Total Score				2.87

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	60.56	1.000	3.98	0	[1 - 100]
returnOnEquityTTM	0.190	2.50	9.36	10.00	[0.1 - 1.5]
freeCashFlowPerShareTTM	28.46	2.00	0.514	10.00	[0 - 30]
dividendYielPercentageTTM	1.000	1.500	10.00	0	[0 - 0.4]
operatingCashFlowPerShareTTM	28.46	2.00	0.514	1.028	[0 - 30]
payoutRatioTTM	0	1.500	0	0	[0 - 1]
pegRatioTTM	0	1.500	-3.33	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0.109	1.000	9.77	0	[0.1 - 0.5]
Total Score				3.08

Dr. Lal PathLabs Limited

Dr. Lal PathLabs Limited provides diagnostic and related healthcare tests and services in India and internationally. It operates laboratories for carrying the pathological investigations of various branches of bio-chemistry, hematology, histopathology, microbiology, electrophoresis, immuno-chemistry, immunology, virology, cytology, and other pathological and radiological investigations. The company also offers lab staff training; technical; and lab management services. As of March 31, 2022, the company had 277 clinical laboratories, including National Reference Lab at Delhi and Regional Reference Lab at Kolkata; and 4,731 patient service centers and 10,599 pick-up points. Dr. Lal PathLabs Limited was founded in 1949 and is based in Gurugram, India.